Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) EBIT Margin (2022 - 2025)

Historic EBIT Margin for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 96880.0%.

  • PAVmed's EBIT Margin changed N/A to 96880.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 69627.59%, marking a year-over-year change of. This contributed to the annual value of 1485.38% for FY2024, which is 13202900.0% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's EBIT Margin is 96880.0%.
  • Over the past 5 years, PAVmed's EBIT Margin peaked at 1389.7% during Q1 2024, and registered a low of 96880.0% during Q3 2025.
  • Over the past 4 years, PAVmed's median EBIT Margin value was 10388.89% (recorded in 2022), while the average stood at 29178.85%.
  • In the last 5 years, PAVmed's EBIT Margin soared by 287829700bps in 2023 and then crashed by -771855800bps in 2025.
  • Quarter analysis of 4 years shows PAVmed's EBIT Margin stood at 21965.18% in 2022, then soared by 93bps to 1561.77% in 2023, then tumbled by -3221bps to 51870.0% in 2024, then plummeted by -87bps to 96880.0% in 2025.
  • Its EBIT Margin was 96880.0% in Q3 2025, compared to 78583.33% in Q2 2025 and 68075.0% in Q1 2025.